Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Authors

Tianqing Chu (ORCID: https://orcid.org/0000-0002-0744-0397)
Rong Qiao (ORCID: https://orcid.org/0009-0001-3668-0162)
Hua Zhong (ORCID: https://orcid.org/0009-0008-3685-5664)
Jun Lü (ORCID: https://orcid.org/0000-0002-7343-9706)
Feng Pan (ORCID: https://orcid.org/0000-0002-8428-7322)
Meili Ma (ORCID: https://orcid.org/0000-0002-8049-9467)
Jiajun Teng
Jialin Qian
Bo Zhang (ORCID: https://orcid.org/0009-0009-0403-3575)
Zhiqiang Gao (ORCID: https://orcid.org/0000-0001-5094-1667)

Institutions

Shanghai Jiao Tong University (CN)
Shanghai Chest Hospital (CN)

Publication Details

Journal: JMIR Research Protocols
Published: 2024-09-28
DOI: https://doi.org/10.2196/64950
Citations: 3
Primary Topic: Lung Cancer Treatments and Mutations
Type: article
Field-Weighted Citation Impact: 1.26

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Tianqing Chu, Rong Qiao, Hua Zhong, Jun Lü et al.

Sep 28, 2024

3 citations

JMIR Research Protocols

Lung Cancer Treatments and Mutations

1.26

article

Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Tianqing Chu, Rong Qiao, Hua Zhong, Jun Lü, Feng Pan, Meili Ma, Jiajun Teng, Jialin Qian, Bo Zhang, Zhiqiang Gao

September 28, 2024article en

3 citations

Abstract

No abstract available for this paper.

JMIR Research ProtocolsVol. 13

Shanghai Jiao Tong University (CN), Shanghai Chest Hospital (CN)

Good health and well-being

Openalex Percentile: Top 19%

Lung Cancer Treatments and Mutations

1.26

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.